Efficacy of tacrolimus extended release formulation as an alternative to ciclosporin A in patient with renal impairment

Trial Profile

Efficacy of tacrolimus extended release formulation as an alternative to ciclosporin A in patient with renal impairment

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2014

At a glance

  • Drugs Tacrolimus (Primary) ; Ciclosporin
  • Indications Graft-versus-host disease; Renal transplant rejection
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 13 Oct 2014 New trial record
    • 01 May 2013 Recruitment completed, according to 55th Annual Meeting and Exposition of the American Society of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top